Position in ABBV
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$3,327,184
+$880,639 QoQ
Shares Held
13,222
+17.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.50%
of 13F equity value
Holder Rank
#1,573
of 4,153 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cornerstone Select Advisors, LLC holds $13,220,810 across 7 Drug Manufacturers - General names. ABBV ranks #1 (25.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
13,222 | $3,327,184 | |
| 2 | MRK |
Merck & Co., Inc.
|
25,523 | $3,279,705 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
18,744 | $2,368,116 | |
| 4 | AMGN |
Amgen Inc
|
4,743 | $1,717,535 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
19,000 | $1,094,780 | |
| 6 | JNJ |
Johnson & Johnson
|
4,100 | $1,041,277 | |
| 7 | LLY |
ELI LILLY & Co
|
327 | $392,213 |
All Filings in ABBV
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,327,184 | 13,222 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $2,446,545 | 11,249 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,495,339 | 10,921 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $2,520,775 | 10,887 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,842,278 | 9,925 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,216,302 | 10,578 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,780,731 | 10,021 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||